CYTED LTD

Company number

11478299

Status

Active

Incorporation

2018-07-23

Last accounts made up

2024-12-31

Account category

GROUP

Primary SIC

86220

Hubs

UK Healthcare

Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers

Accounting basis

FRS 102 §1A

Reporting scope

Consolidated (group)

Abridged

Yes — abridged accounts (limited disclosure)

Auditor

RSM UK Audit LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The Group has net current assets of £1,892,826. Therefore, the directors have a reasonable expectation that the group has adequate resources to continue in operational existence for at least 12 months following the signature of these financial statements which assume that no significant uncertainty could exist in respect of this decision. As part of the going concern assessment, sensitivities have been prepared against group forecasts to assess the impact on the business should current pipeline opportunities not be converted and/or additional funding is not secured. In this scenario, the business can undertake an expenditure review program to manage the necessary levers to maintain and/or reduce group expenditure where needed. The directors are confident that this can be implemented, without any material impact on existing customer contracts whilst ensuring the group will continue to settle its liabilities as and when they fall due. In the event that additional funding is not obtained, the convertible loan note holders could issue a redemption notice at the end of the term, on 1 February 2026. After the period end the holders have agreed to extend the term date to 1 February 2027, which removes the potential cash outflow outside of the going concern assessment. On this basis, the directors are satisfied that without future funding they have the ability and time to control spend where necessary, so it remains appropriate to prepare the financial statements on a going concern basis.”

Subsidiaries

• Cyted UK Ltd · 100% held · UK · Provision of digital diagnostic infrastructure
• Cyted Health Ltd · 100% held · UK · Provision of digital diagnostic infrastructure
• Cyted Health Inc · 100% held · US · Provision of digital diagnostic infrastructure

Significant events

• “In May 2025, the Company completed the sale of its subsidiary, Cyted UK Limited. The sale was finalised after the balance sheet date and is considered a non-adjusting event under FRS 102.”

Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers